In the present study, we firstly found prognostic significance of B-Myb in NSCLC, and a loss-of-function study demonstrated that downregulation of B-Myb significantly suppressed NSCLC cell growth, cell cycle progression, colony-forming ability, motility, and tumorigenesis in vivo. The gene discussed is MYBL2; the disease is non-small cell lung carcinoma.